HC Wainwright Estimates Novavax’s Q3 Earnings (NASDAQ:NVAX)
Stock analysts at HC Wainwright issued their Q3 2024 earnings estimates for shares of Novavax in a note issued to investors ...
Nasdaq3d
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
Novavax NVAX was in focus this week as investors were ... achieving sustained target inhibition for three months. The Nasdaq Biotechnology Index has lost 1.94% in the past five trading sessions ...
Nasdaq5d
NVAX Earnings: Novavax Stock Down on Weak 2024 Revenue Outlook
Shares of Novavax (NVAX), a pharmaceutical company, declined over 6% following the release of its third-quarter results. Though the company reported a lower-than-expected loss and surpassed ...
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today ...
Nasdaq6d
Spotlight on Novavax: Analyzing the Surge in Options Activity
Deep-pocketed investors have adopted a bullish approach towards Novavax (NASDAQ:NVAX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Hosted on MSN4d
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning and welcome to Novavax' ...
Nasdaq5d
Novavax Becomes Oversold (NVAX)
In trading on Tuesday, shares of Novavax, Inc. (Symbol: NVAX) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $7.89 per share. By comparison ...
Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price
Novavax, Inc. ( NASDAQ:NVAX ) investors will be delighted, with the company turning in some strong numbers with ...
Nasdaq12d
Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
The market expects Novavax (NVAX) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus ...
Nasdaq6d
Notable Monday Option Activity: NVAX, NTRA, ALB
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Novavax, Inc. (Symbol: NVAX), where a total of 61,950 contracts have traded so far ...
Nasdaq5d
Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates
Novavax (NVAX) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.87. This compares to loss of $1.26 per share a year ago. These figures are ...
Morningstar3d
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
GAITHERSBURG, Md., Nov. 15, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the ...